Article Details
Retrieved on: 2024-08-08 21:41:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a novel biotechnology approach using affibody molecules and nanotechnology to increase extracellular PGRN levels for treating FTD caused by GRN mutations. Techniques like phage display, surface plasmon resonance, and antibody alternatives were applied for this purpose.
Article found on: www.frontiersin.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here